ERYtech Pharma, Inc. (ERYtech)

Oncology Corporate Profile

HQ Location

3711 Market Street
Philadelphia, PA 19104

Company Description

ERYtech Pharma is a specialty pharma company developing innovative therapeutic solutions based on its proprietary technology and expertise in the physiological properties of erythrocytes. The company addresses serious pathologies, orphan indications or sub-populations of patients, particularly in the fields of haematology, cancer and metabolic diseases.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
Graspa_ encapsalated L-asparaginaseAcute Lymphocytic Leukemia (ALL)II
Graspa_ encapsalated L-asparaginaseAcute Myelogenous Leukemia (AML)II
Graspa_ encapsalated L-asparaginasePancreatic cancerII
Graspa_ encapsalated L-asparaginasePancreatic cancerII
Graspa_ encapsalated L-asparaginaseDiffuse large B-cell Lymphoma (DLBCL)Preclinical
Graspa_ encapsalated L-asparaginaseVarious cancer typesPreclinical

View additional information on product candidates here »

Pipeline image


Recent News Headlines

There are no news items to display